# Shigehiro Katayama

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shigehiro-katayama/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,109 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 53 |
| i10-index | 168 |
| Last Known Institution | Institute for Advanced Study |
| OpenAlex ID | https://openalex.org/A5006861620 |
| ORCID iD | 0000-0001-7726-0255 |
| Works | 315 |

## Researcher papers

- [VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death](https://scholariq.org/papers/vegf-is-a-modifier-of-amyotrophic-lateral-sclerosis-in-mice-and-humans-and/)
- [Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes](https://scholariq.org/papers/olmesartan-for-the-delay-or-prevention-of-microalbuminuria-in-type-2-diabetes/)
- [A Common Polymorphism in the 5′-Untranslated Region of the VEGF Gene Is Associated With Diabetic Retinopathy in Type 2 Diabetes](https://scholariq.org/papers/a-common-polymorphism-in-the-5-untranslated-region-of-the-vegf-gene-is/)
- [Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1](https://scholariq.org/papers/essential-role-of-p38-mitogen-activated-protein-kinase-in-cathepsin-k-gene/)
- [Noninvasive Evaluation of Kidney Hypoxia and Fibrosis Using Magnetic Resonance Imaging](https://scholariq.org/papers/noninvasive-evaluation-of-kidney-hypoxia-and-fibrosis-using-magnetic-resonance/)
- [Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial](https://scholariq.org/papers/effect-of-an-intensified-multifactorial-intervention-on-cardiovascular-outcomes/)
- [Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect](https://scholariq.org/papers/lipophilic-hmg-coa-reductase-inhibitor-has-an-anti-inflammatory-effect/)
- [The ligands/activators for peroxisome proliferator-activated receptor  α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells](https://scholariq.org/papers/the-ligands-activators-for-peroxisome-proliferator-activated-receptor-ppar-and/)
- [Prevention of Transition From Incipient to Overt Nephropathy With Telmisartan in Patients With Type 2 Diabetes](https://scholariq.org/papers/prevention-of-transition-from-incipient-to-overt-nephropathy-with-telmisartan-in/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney function](https://scholariq.org/papers/efficacy-and-safety-of-finerenone-in-asian-patients-with-type-2-diabetes-and-2/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)

## Researcher university

- [Institute for Advanced Study](https://scholariq.org/institutions/institute-for-advanced-study-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.